Crossmark

Efficacy of Hwangryunhaedok-tang (Huang-lian-jie-du-tang, Oren-gedoku-to) for patients with hyperlipidemia: a study protocol for a randomized, double-blind, placebo-controlled, parallel, investigator-initiated clinical trial

Crossref DOI link: https://doi.org/10.1186/s13063-020-04695-3

Published Online: 2020-08-27

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lee, Boram

Han, Kyungsun

Park, Hyo-Ju

Kim, Ae-Ran

Kwon, O-Jin

Yang, Changsop https://orcid.org/0000-0003-1277-3329
Cho, Chung-Sik
Funding

Funding for this research was provided by:

Korea Institute of Oriental Medicine (KSN1522120)
License Information

Text and Data Mining valid from 2020-08-27

Version of Record valid from 2020-08-27
More Information

Article History

Received: 9 January 2020

Accepted: 16 August 2020

First Online: 27 August 2020

Ethics approval and consent to participate

: The trial protocol has been approved by the Korea Ministry of Food and Drug Safety (approval number: 32578) and the IRB of Daejeon Korean Medicine Hospital of Daejeon University (approval number: DJDSKH-19-DR-18). Informed consent will be obtained from all study participants.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below